Articles about Treatment

• The FDA granted accelerated approval to a novel immunotherapy combination for metastatic pancreatic cancer on March 21, 2026, based on Phase 2 trial data showing a 35% response rate. • The drug combination demonstrated a median overall survival of 14.2 months compared to 11.8 months with standard chemotherapy in the clinical trial of 280 patients. • Pancreatic cancer remains one of the deadliest cancers with a five-year survival rate below 12%, making this approval potentially significant for the estimated 64,000 Americans diagnosed annually.

Judge rules that Trump’s health secretary did not go through proper procedures when issuing declarationRobert F Kennedy Jr, the health secretary, overstepped his power when he declared that gender-affirming treatments are unsafe, a federal judge has ruled.In a blow to the Trump administration’s attempts to limit access to gender transition procedures, Judge Mustafa Kasubhai ruled Thursday that Kennedy did not go through the proper procedures when issuing his 12-page declaration last December. Continue reading...

Exclusive: Drug users face felonies and prison under Prop 36, with analysis showing racial disparities and little helpCalifornia prosecutors have filed nearly 20,000 drug possession felony cases under a tough-on-crime measure passed in 2024. But despite promises to get people into services, the vast majority of those arrested have not received drug treatment, state data reveals.Proposition 36, a state ballot measure, enacted harsher penalties for minor theft and drug offenses, with proponents pledging the crackdown would lead to “mass treatment to keep people alive, out of jail, and off our streets”. Continue reading...

International researchers find ‘very little evidence’ medical form of the drug can treat anxiety, anorexia and other disordersCannabis is not an effective treatment for common mental health conditions despite the global surge in patients using it for that purpose, a review has found.Researchers concluded there was “very little evidence for its efficacy” in treating anxiety, anorexia nervosa, psychotic disorders, post-traumatic stress disorder or opioid use disorder. Continue reading...

California's 2024 Proposition 1 mental health bond has failed to open ten promised treatment centers as of March 2026, despite initial assurances of rapid deployment. The California Department of Health Care Services attributed delays to permitting issues, site conditions, and supply-chain strain from President Trump's tariffs, though officials stated most construction remains on schedule. The $6.4 billion measure was designed to expand mental health treatment capacity, but the implementation setbacks raise questions about the state's ability to address its growing mental health crisis.